Interestingly, these findings are consistent with evidence demonstrating that the exercise-induced reshaping of WAT functionality warrants a decrease in CCL-2 [19,121,122], suggesting that the modulation of WAT may be critical for regulating plasma CCL-2 levels in obesity. The gene discussed is CCL2; the disease is Obesity.